The highlight of the British GT season is undoubtedly the trip across the English Channel into Europe to race at the historic Spa Francorchamps circuit.
The seven kilometre track is a relentless challenge for both Car and Driver with arguably the world’s greatest corner, Eau Rouge, the standout feature of the track.
Although the AMG GT4 was new to MPS and Team Parker Racing, expectations were high as they already shown a great pace from the outset of the season and motivation was high to carry over this performance on to one of the World’s greatest circuits.
The British GT event on the continent formed part of the SRO’s Speed week at the Spa circuit, which also hosted the European GT4 series, resulting in a large number of comparable AMG GT4 machinery running on the same track in the same specification and with the same balance of performance. This added another level of competition for MPS and the TPR team.
Despite this large amount of competition, MPS and TPR rose to the top of both the standings for the Mercedes AMG GT4’s as well as the entire GT4 class in their championship.
Engineer and driver working in harmony in testing allowed the team to develop a set up for the car which allowed Pro driver Scott Malvern to set the fastest time in the Qualifying session.
This high performance platform allowed Amateur driver Nick Jones to produce one of his best performances on track to date during the start of the race.
This coupled with a great race strategy and slick pit stop by the team allowed Scott Malvern to enter the second part of the race in contention for the win.
He performed to his usual professional standards throughout the stint to take the checkered flag and in the process securing the team’s first ever GT4 win and giving them the opportunity to be stood at the top step of the prestigious Spa Francorchamps podium.
In only their second year of working together, it was great for MPS and TPR to be able to demonstrate all of the hard work by not only wining their Pro Am class, but also winning the GT4 class overall.